Dia Spectr
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Spectrum 21:154-155, 2008
DOI: 10.2337/diaspect.21.3.154
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boucher, J. L.
Right arrow Articles by Hurrell, D. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Boucher, J. L.
Right arrow Articles by Hurrell, D. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Preface

Cardiovascular Disease and Diabetes

Jackie L. Boucher, MS, RD, CDE and David G. Hurrell, MD, FACC, Guest Editors

The first 20% of the full text of this article appears below.

The International Diabetes Federation estimates that diabetes accounts for ~ 6% of total global mortality, with 50% of diabetes-associated deaths being attributed to cardiovascular disease (CVD).1 Individuals with diabetes have twice the incident myocardial infarction (MI) rate as the general population, and survival rates are lower among individuals with diabetes once they have an adverse cardiovascular event.2 Women with diabetes and CVD, regardless of menopausal status, have a four- to sixfold increase in the risk of developing CVD, whereas men with diabetes have a two- to threefold increased risk of CVD compared to women and men without diabetes.3 Women with diabetes also have poorer prognosis after an MI, have higher risk of death from CVD than men, and typically receive less aggressive treatment to achieve treatment goals.3

Because individuals with diabetes are at higher risk for CVD events than individuals without diabetes and are at risk for future events if they have already had one, most national guidelines consider CVD in their recommendations for people with diabetes.2 Comprehensive guidelines, improved diagnosis, and effective treatments have definitely helped decrease mortality from CVD during the past few decades, but there is still more clinicians can do to help . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.